CClinicalTrials.gg
Enrolling by invitationNCT06992570Updated Nov 19, 2025

Risk Assessment of Mild Traumatic Brain Injury in Military Training

An interventional study of Quantification of mild trauma brain injury risk and Biomechanical Analysis of Head Impact Forces in Trauma, Brain, sponsored by Charles University, Czech Republic. Enrolling by invitation at 1 site in Czechia. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-19.

Sponsored by Charles University, Czech Republic · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Jun 2026, 3 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The SNIPER-TBI study aims to identify and quantify the risk of mild traumatic brain injury (mTBI) in soldiers of the Czech Armed Forces during specific high-risk training activities, including parachute jumps, high-caliber firearms shooting, artillery blasts, and Close Quarters Battle (CQB) exercises. The study will utilize both diagnostic biomarker analysis and experimental biomechanical measurements to assess the physiological impact of these activities on brain health. The ultimate goal is to reduce mTBI incidence, improve operational readiness, and extend the active service duration of soldiers through targeted preventive measures.

Read the detailed description

The SNIPER-TBI study aims to quantify the risk of mild traumatic brain injury (mTBI) in Czech Armed Forces soldiers during high-risk training activities, including parachute jumps, high-caliber firearms shooting, artillery blasts, and Close Quarters Battle (CQB) exercises. The study combines diagnostic biomarker analysis (GFAP, UCH-L1) and experimental biomechanical measurements using wearable sensors and high-speed cameras. These data will provide critical insights into the forces exerted on the brain during training and help establish exposure limits to minimize long-term neurological impairment. The results will guide the development of protective strategies and enhance soldier readiness.

02

Conditions studied

  • Trauma, Brain

Keywords

  • mTBI
  • Biomechanics
  • Military Training
03

In context

Brain Injuries, Traumatic

1,775 studies on the registry are indexed under Brain Injuries, Traumatic; 448 are open to participants now.

This study's planned enrollment of 50 is below the median of 56 across 1,133 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Charles University, Czech Republic is the lead sponsor of 220 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age 18-50 years
  • Active-duty military personnel
  • Participating in designated high-risk training activities

Exclusion criteria

Exclusion Criteria:

  • History of significant brain injury
  • Current neurological disorders
  • Use of anticoagulant medications
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    High-Risk Military Training Exposure

    Active-duty soldiers participating in high-risk training activities, including parachute jumps, high-caliber firearms shooting, artillery blasts, and Close Quarters Battle (CQB) exercises. Participants will undergo real-time biomechanical measurement and biomarker analysis to assess mild traumatic brain injury (mTBI) risk. Diagnostic biomarker analysis (GFAP, UCH-L1) Real-time biomechanical monitoring (accelerometers, high-speed cameras)

    Diagnostic Test: Quantification of mild trauma brain injury risk · Other: Biomechanical Analysis of Head Impact Forces

Interventions

  • Diagnostic testQuantification of mild trauma brain injury risk

    Measure the incidence and severity of mTBI among soldiers engaged in high-risk training activities. (e.g. parachute jumps, high-caliber firearms shooting, artillery fire, explosions). Concentration of brain injury biomarkers (GFAP, UCH-L1) in blood samples collected within 24 hours post-exposure

  • OtherBiomechanical Analysis of Head Impact Forces

    Evaluate the mechanical forces experienced by soldiers during high-risk activities using wearable accelerometers and high-speed video analysis. Peak head acceleration (g-force) and pressure wave analysis during training activities.

06

What researchers measure

Primary outcomes

  1. Quantification of mTBI Risk 1

    Measure the severity of mTBI among soldiers engaged in high-risk training activity. Concentration of brain injury biomarker glial fibrillary acidic protein (GFAP) in blood sample collected within 24 hours post-exposure. Measured in nanogram per milliliter.

    Time frame: Up to 24 hours post-exposure

  2. Quantification of mTBI Risk 2

    Measure the severity of mTBI among soldiers engaged in high-risk training activity. Concentration of brain injury biomarker ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) in blood sample collected within 24 hours post-exposure. Measured in nanogram per milliliter.

    Time frame: Up to 24 hours post-exposure

  3. Biomechanical Analysis of Head Impact Forces 1

    Evaluate the mechanical forces experienced by soldiers during high-risk activity using wearable accelerometers and high-speed video analysis. Peak head acceleration (g-force) will be measured during training activity. Measured in meters per second squared.

    Time frame: Baseline

  4. Biomechanical Analysis of Head Impact Forces 2

    Evaluate the mechanical forces experienced by soldiers during high-risk activities using wearable accelerometers and high-speed video analysis. Pressure wave during training activity will be analyzed. Measures in Pascal.

    Time frame: Baseline

07

Study locations

1 site
  • Military University Hospital Prague
    Prague, Czech Republic 16902, Czechia
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to concerns regarding participant confidentiality, data privacy, and the sensitive nature of the study involving military personnel.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06992570
Lead sponsor
Charles University, Czech Republic
Collaborators
Military University Hospital, Prague
Responsible party
Michal Soták (Principal Investigator, Charles University, Czech Republic) — Principal investigator
First posted
May 28, 2025
Start date
Nov 4, 2025
Primary completion
Jun 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Nov 19, 2025

Study contacts

Michal Soták, M.D., Ph.D.
principal investigator · Military University Hospital, Prague

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion